Loading stock data…
TMO
$452.60-12.40 (-2.67%)
Market ClosedLast close May 11
Thermo Fisher Scientific Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Thermo Fisher Scientific Inc. in the Healthcare sector is trading at $452.60. The stock is currently 30% below its 52-week high of $643.99, remaining 14.1% below its 200-day moving average. Technical signals show oversold RSI of 23 and bearish MACD signal, explaining why TMO maintains its current current market pressure. The Whystock Score of 25/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Oversold momentum (RSI 23) — potential for technical mean-reversion
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$452.60
Potential Downside
29.4%
Whystock Fair Value$319.52
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. It operates through four se...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$191.01B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
28.99
Beta
Defensive asset. Lower volatility than the S&P 500.
0.97
Div Yield
Strong income play. Yield provides a meaningful total return floor.
34.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
12.33%
Volume
Today's trading volume
3.95M
Recent News
Thermo Fisher Expands Cell Therapy And Hydration Platforms To Deepen Ecosystem
Thermo Fisher Scientific (NYSE:TMO) has introduced the Gibco CTS DynaXS Single Use Bioreactor, targeting cell therapy manufacturing. The company has opened its flagship U.S. Bioprocess Design Center in Massachusetts to support biologics and advanced therapy development. Thermo Fisher is a top vendor in the growing DNA synthesis market and is expanding its Nalgene Outdoor hydration product line. Thermo Fisher Scientific, with a current share price of $465.0, operates at the intersection of...
Jim Cramer on Thermo Fisher: “I Think You Can Buy It at This Level”
Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the stocks Jim Cramer shared his thoughts on as he discussed Big Tech’s AI spending. A caller asked whether the stock is a buy, sell, or hold. In response, Cramer said: I like it here. I see so many IPOs every morning that Carl mentions, and they’re […]
Is It Time To Revisit Thermo Fisher Scientific (TMO) After This Year’s Share Price Pullback
Wondering if Thermo Fisher Scientific at around US$472.95 is offering good value right now, or if the stock has already run ahead of itself. The share price has been mixed recently, with a 1.4% gain over the last 7 days, a 3.1% decline over the last 30 days, and a 20.2% decline year to date, even though the 1 year return sits at 16.4%. These moves come against a backdrop of ongoing attention on Thermo Fisher Scientific as a major supplier of life sciences tools and services, with investors...
Agilent Technologies Names Michael Buckner as CLO
By Karen Roman Agilent Technologies, Inc. (NYSE: A) said it designated Michael Buckner as Chief Legal Officer, having previously served at Danaher as Vice President, Deputy General Counsel, and Chief M&A Counsel. Mr. Buckner has nearly 30 years of experience as a senior global legal executive with experience in complex transactions and regulatory environments, the […]
Top Stock Reports for Alphabet, Walmart & Micron
Alphabet rides AI-driven growth across Search, Cloud and subscriptions, but rising spending, debt and legal risks temper near-term flexibility.